Related Experiment Video
Updated: Aug 11, 2026

Cellular Redox Profiling Using High-content Microscopy
Published on: May 14, 2017
Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on
Hélène C F Côté1, Alex B Magil, Marianne Harris
1British Columbia Centre for Excellence in HIV/AIDS, Providence Health Care, Vancouver, BC, Canada. helene.cote@ubc.ca
Background:
Tenofovir (TDF) exposure has been associated with renal dysfunction. Mitochondrial nephrotoxicity was investigated as an underlying mechanism. Given the interaction between TDF and didanosine (ddl), their concurrent use was also investigated.
Design:
Relative kidney biopsy mitochondrial DNA (mtDNA) to nuclear DNA ratios were measured retrospectively. HIV+ individuals on TDF within 6 months preceeding the biopsy (HIV+/TDF+, n=21) were compared to HIV+ individuals who never received TDF (HIV+/TDF-, n=10) and to HIV uninfected controls (HIV-,n=22). Twelve of the HIV+/TDF+ individuals received concurrent ddl, 10 of those once at unadjusted ddl dosage. Tubular mitochondria morphology was also examined by electron microscopy. Statistical analyses were done on log-transformed mtDNA/nDNA, using non-parametric tests.
Results:
Kidney mtDNA levels were different among the three groups (P=0.046). mtDNA ratios were lower in HIV+/TDF+ subjects (7.5 [2.0-12.1]) than in HIV- ones (14.3 [6.0-16.5], P=0.014), but not lower than HIV+/TDF- controls (6.4 [2.8-11.9], P=0.82). Among HIV+ subjects, there was a difference between TDF-, TDF+/ddl- and TDF+/ddl+ (P=0.005), with concurrent TDF/ddl use associated with lower mtDNA (2.1 [1.9-5.5], n=12) than TDF+/ddl- (13.8 [7.5-16.4], n=9, P=0.003). No TDF-/ddl+ biopsies were available. In regression analyses, only HIV infection (P=0.03), and TDF/ddl use (P=0.003) were associated with lower mtDNA. At the ultrastructural level, abnormal tubular mitochondria was more prevalent in HIV+/TDF+ biopsies than HIV+/TDF- and HIV- ones together (P<0.001) but not more so in TDF+/ddl+ biopsies than TDF+/ddl- ones (P=0.67).
Conclusions:
Renal dysfunction in this population may be mediated through mitochondrial nephrotoxicity that involves more than one drug and/or pathogenesis. Kidney mtDNA depletion was associated with HIV infection and concurrent TDF/ddl therapy but not TDF use alone, while kidney ultrastructural mitochondrial abnormalities were seen with TDF use. The interaction between TDF and ddl may be relevant in the kidney where both drugs are cleared. The clinical relevance of our findings needs to be evaluated given the current recommendation for reduced doses of ddl when used in conjunction with TDF.
Insights
Concurrent use of tenofovir (TDF) and didanosine (ddl) in HIV patients is linked to kidney mitochondrial DNA depletion. TDF use alone showed mitochondrial abnormalities, suggesting complex drug interactions contribute to renal dysfunction.
Area of Science:
- Nephrology
- Virology
- Pharmacology
Background:
- Tenofovir (TDF) use is associated with renal dysfunction.
- Mitochondrial nephrotoxicity is a potential mechanism underlying TDF-induced kidney injury.
- The interaction between TDF and didanosine (ddl) warrants investigation regarding concurrent use and renal effects.
Purpose of the Study:
- To investigate mitochondrial nephrotoxicity as a mechanism for renal dysfunction in HIV+ individuals exposed to TDF.
- To compare kidney mitochondrial DNA (mtDNA) to nuclear DNA (nDNA) ratios in HIV+ individuals on TDF, HIV+ individuals not on TDF, and HIV- uninfected controls.
- To examine the impact of concurrent TDF and ddl use on kidney mtDNA levels and mitochondrial morphology.
Main Methods:
- Retrospective analysis of kidney biopsy samples.
- Measurement of relative mtDNA to nDNA ratios.
- Comparison of three groups: HIV+/TDF+ (n=21), HIV+/TDF- (n=10), and HIV- (n=22).
- Examination of tubular mitochondria morphology via electron microscopy.
- Statistical analysis using non-parametric tests on log-transformed mtDNA/nDNA ratios.
Main Results:
- Kidney mtDNA levels differed significantly among the groups (P=0.046).
- HIV+/TDF+ subjects had lower mtDNA ratios compared to HIV- controls (P=0.014), but not HIV+/TDF- controls (P=0.82).
- Concurrent TDF/ddl use was associated with significantly lower mtDNA levels (P=0.003) compared to TDF use without ddl.
- Abnormal tubular mitochondria were more prevalent in HIV+/TDF+ biopsies (P<0.001).
- Regression analysis identified HIV infection and concurrent TDF/ddl use as associated with lower mtDNA.
Conclusions:
- Renal dysfunction in this population may involve mitochondrial nephrotoxicity, potentially involving multiple drugs.
- Kidney mtDNA depletion is linked to HIV infection and concurrent TDF/ddl therapy, not TDF alone.
- Ultrastructural mitochondrial abnormalities in the kidney are associated with TDF use.
- The interaction between TDF and ddl is clinically relevant for kidney function, especially given current dosing recommendations.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Retrovirus Life Cycles
Cryptococcal Meningitis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

